The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma

Objective: This study aimed to evaluate the applicability of adenosine deaminase (ADA), α-l-fucosidase (AFU), lactic acid (LAC), and their combined detection in the early diagnosis of chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Methods: A retrospective analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Chen, Zhong, Xue, Chengjun, Zhang, Yao, Wu, Lipei, Zhu, Jichao, Xuan, Shihai, Tian, Jiale, Pang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453082/
https://www.ncbi.nlm.nih.gov/pubmed/34557505
http://dx.doi.org/10.3389/fmed.2021.740029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453082/
https://www.ncbi.nlm.nih.gov/pubmed/34557505
http://dx.doi.org/10.3389/fmed.2021.740029

Ejemplares similares